These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8561815)

  • 1. [Diagnosis of endolymphatic hydrops with low tone masked otoacoustic emissions].
    Nubel K; Kabudwand E; Scholz G; Mrowinski D
    Laryngorhinootologie; 1995 Nov; 74(11):651-6. PubMed ID: 8561815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of endolymphatic hydrops by low-frequency masking.
    Mrowinski D; Scholz G; Krompass S; Nubel K
    Audiol Neurootol; 1996; 1(2):125-34. PubMed ID: 9390796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Aural fullness and endolymphatic hydrops].
    Gossow-Müller-Hohenstein E; Hirschfelder A; Scholz G; Mrowinski D
    Laryngorhinootologie; 2003 Feb; 82(2):97-101. PubMed ID: 12624836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distortion-product otoacoustic emissions and cochlear microphonics: relationships in patients with and without endolymphatic hydrops.
    Fetterman BL
    Laryngoscope; 2001 Jun; 111(6):946-54. PubMed ID: 11404602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous otoacoustic emissions in humans with endolymphatic hydrops.
    Haginomori SI; Makimoto K; Tanaka H; Araki M; Takenaka H
    Laryngoscope; 2001 Jan; 111(1):96-101. PubMed ID: 11192908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical application of transiently evoked otoacoustic emissions after glycerol administration for diagnosis of sensorineural hearing loss.
    Inoue Y; Kanzaki J; O-Uchi T; Ogawa K; Ogata A; Yoshihara S; Satoh Y
    Auris Nasus Larynx; 1997 Apr; 24(2):143-9. PubMed ID: 9134136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of low-frequency biasing as a diagnostic tool in Menière patients.
    Hof-Duin NJ; Wit HP
    Hear Res; 2007 Sep; 231(1-2):84-9. PubMed ID: 17658231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Animal experiment studies using a low-frequency, phase-delayed masker in inner ear diagnosis].
    Höhmann D
    HNO; 1993 Sep; 41(9):426-35. PubMed ID: 8226129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An alternative diagnostic test for active Ménière's disease and cochlear hydrops using high-pass noise masked responses: the complex amplitude ratio.
    Don M; Kwong B; Tanaka C
    Audiol Neurootol; 2007; 12(6):359-70. PubMed ID: 17664867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distortion-product otoacoustic emissions and glycerol testing in endolymphatic hydrops.
    Magliulo G; Cianfrone G; Triches L; Altissimi G; D'Amico R
    Laryngoscope; 2001 Jan; 111(1):102-9. PubMed ID: 11192876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase-dependent suppression of transient evoked and distortion product otoacoustic emissions by a low-frequency tone.
    Scholz G; Mrowinski D; Hensel J
    Audiology; 1999; 38(5):271-5. PubMed ID: 10548375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comparison of Distortion Product Otoacoustic Emission Properties in Ménière's Disease Patients and Normal-Hearing Participants.
    Drexl M; Krause E; Gürkov R
    Ear Hear; 2018; 39(1):42-47. PubMed ID: 28671918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endolymphatic hydrops in Meniere's disease detected by MRI after intratympanic administration of gadolinium: comparison with sudden deafness.
    Horii A; Osaki Y; Kitahara T; Imai T; Uno A; Nishiike S; Fujita N; Inohara H
    Acta Otolaryngol; 2011 Jun; 131(6):602-9. PubMed ID: 21344957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease?
    Junicho M; Aso S; Fujisaka M; Watanabe Y
    Acta Otolaryngol; 2008 Mar; 128(3):304-8. PubMed ID: 18274917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis of endolymphatic hydrops using low frequency modulated distortion product otoacoustic emissions].
    Hirschfelder A; Gossow-Müller-Hohenstein E; Hensel J; Scholz G; Mrowinski D
    HNO; 2005 Jul; 53(7):612-7. PubMed ID: 15565422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early diagnosis of endolymphatic hydrops with distortion. Product otoacoustic emissions.
    Magliulo G; Cianfrone G; Di Cello P; Tersigni A
    An Otorrinolaringol Ibero Am; 2004; 31(2):173-89. PubMed ID: 15185614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in otoacoustic emission during the glycerol test in the ears of patients with Meniere's disease].
    Sakashita T; Kubo T; Kyunai K; Ueno K; Hikawa C; Shibata T; Yamane H; Kusuki M; Wada T; Uyama T
    Nihon Jibiinkoka Gakkai Kaiho; 2001 Jun; 104(6):682-93. PubMed ID: 11494522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semi-quantitative evaluation of endolymphatic hydrops by bilateral intratympanic gadolinium-based contrast agent (GBCA) administration with MRI for Meniere's disease.
    Fukuoka H; Tsukada K; Miyagawa M; Oguchi T; Takumi Y; Sugiura M; Ueda H; Kadoya M; Usami S
    Acta Otolaryngol; 2010; 130(1):10-6. PubMed ID: 19363714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of inner ear hearing loss on delayed otoacoustic emissions (TEOAE) and distortion products (DPOAE)].
    Hoth S
    Laryngorhinootologie; 1996 Dec; 75(12):709-18. PubMed ID: 9081275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A human temporal bone study of changes in the basilar membrane of the apical turn in endolymphatic hydrops.
    Nageris B; Adams JC; Merchant SN
    Am J Otol; 1996 Mar; 17(2):245-52. PubMed ID: 8723956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.